Related Experiment Video
Updated: Jun 9, 2025
09:49
Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
Published on: December 28, 2021
3.3K
Testosterone Replacement in Men with Sexual Dysfunction: An Abridged Version of the Cochrane Systematic Review
Hunju Lee1, Eu Chang Hwang2,3, Cheol Kyu Oh4
1Department of Preventive Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea.
The World Journal of Men'S Health
|October 22, 2024
Summary
Testosterone replacement therapy (TRT) showed no significant improvements in erectile function or sexual quality of life for men with sexual dysfunction. The study found TRT did not impact cardiovascular mortality or adverse events compared to placebo.
Area of Science:
- Endocrinology
- Men's Health
- Clinical Trials
Background:
- Sexual dysfunction affects a significant number of men.
- Testosterone replacement therapy (TRT) is a potential treatment option.
- Evidence on TRT's efficacy and safety in sexual dysfunction remains debated.
Purpose of the Study:
- To evaluate the comparative effectiveness of TRT versus placebo or other treatments for male sexual dysfunction.
- To assess TRT's impact on erectile function, sexual quality of life, and cardiovascular outcomes.
- To analyze TRT's association with adverse events and urological symptoms.
Main Methods:
- A systematic review and meta-analysis of randomized controlled trials (RCTs).
- Comprehensive literature search conducted up to August 29, 2023, with no language or publication status restrictions.
- Inclusion criteria focused on RCTs assessing TRT in men with sexual dysfunction.
Main Results:
- Analysis of 43 RCTs involving 11,419 participants.
- TRT demonstrated little to no difference in erectile function (IIEF-EF) compared to placebo (MD: 2.37, 95% CI: 1.67 to 3.08).
- No significant differences were observed in sexual quality of life (Aging Males' Symptoms scale), cardiovascular mortality, or treatment withdrawals due to adverse events, prostate issues, or lower urinary tract symptoms.
Conclusions:
- TRT does not appear to offer significant benefits for erectile function or sexual quality of life in men with sexual dysfunction.
- TRT showed no increased risk of cardiovascular mortality or urological adverse events compared to placebo.
- Current evidence suggests limited advantages of TRT for the studied outcomes in this population.
Related Concept Videos
01:20Disorders of the Male Reproductive System
342
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
342
01:17Male Sexual Response: Erection & Ejaculation
1.7K
Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
1.7K
01:26Testosterone: Functions and Regulation
566
The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
566
01:23Infertility in Males
253
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
253
01:28Menopause
143
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
143
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
129
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
129